Unlock stock picks and a broker-level newsfeed that powers Wall Street.
7.18
+0.15
+(2.13%)
At close: 4:00:00 PM EDT
6.83
-0.35
(-4.87%)
After hours: 6:13:13 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 18 | 18 |
| Avg. Estimate | -1.01 | -1.08 | -4.05 | -4.02 |
| Low Estimate | -1.58 | -1.61 | -5.71 | -6.89 |
| High Estimate | -0.51 | -0.53 | -2.13 | 0.32 |
| Year Ago EPS | -0.97 | -0.49 | -2.77 | -4.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 17 | 20 | 20 |
| Avg. Estimate | 39.82M | 40.11M | 190.97M | 210.11M |
| Low Estimate | -- | -- | 100M | 100M |
| High Estimate | 70.8M | 70.8M | 315.2M | 537.5M |
| Year Ago Sales | 25.3M | 76.5M | 263.4M | 190.97M |
| Sales Growth (year/est) | 57.40% | -47.57% | -27.50% | 10.03% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.38 | -0.59 | -0.87 | -0.96 |
| EPS Actual | -0.97 | -0.49 | -0.68 | -0.63 |
| Difference | 0.41 | 0.1 | 0.19 | 0.33 |
| Surprise % | 29.96% | 16.58% | 21.80% | 34.29% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.01 | -1.08 | -4.05 | -4.02 |
| 7 Days Ago | -1 | -1.07 | -3.92 | -4.09 |
| 30 Days Ago | -1.02 | -1.09 | -3.95 | -4.21 |
| 60 Days Ago | -1.24 | -1.31 | -4.68 | -4.2 |
| 90 Days Ago | -1.27 | -1.36 | -4.7 | -4.25 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | 1 |
| Up Last 30 Days | 3 | 3 | 3 | 5 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 2 | 2 | 6 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ARVN | -3.90% | -119.54% | -46.32% | 0.81% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/14/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/13/2025 |
| Maintains | Guggenheim: Buy to Buy | 3/13/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/12/2025 |
| Maintains | BMO Capital: Outperform to Outperform | 3/12/2025 |
| Downgrade | Wedbush: Outperform to Neutral | 3/12/2025 |
Related Tickers
KYMR Kymera Therapeutics, Inc.
26.36
+4.46%
RCKT Rocket Pharmaceuticals, Inc.
6.30
+8.43%
WVE Wave Life Sciences Ltd.
7.57
-2.20%
RLAY Relay Therapeutics, Inc.
2.4900
+0.81%
APLS Apellis Pharmaceuticals, Inc.
23.00
+1.41%
CCCC C4 Therapeutics, Inc.
1.5200
+5.92%
SWTX SpringWorks Therapeutics, Inc.
46.52
+11.08%
BCYC Bicycle Therapeutics plc
8.05
+2.55%
RVMD Revolution Medicines, Inc.
34.60
+2.91%
BPMC Blueprint Medicines Corporation
90.01
+4.74%